111567-19-2 (2H-5a,2,5-(甲氧基亚甲基)萘[1,2-d]oxepin-4,10(5H,6H)-二酮,1,7,7a,11,11a,11b-六氢-1,6,11-三羟基-8,11a,14-三甲基-,(1R,2S,5R,5aR,6R,7aS,11S,11aS,11bR,14S)-(9CI),2H-5a,2,5-(Methanoxymetheno)naphth[1,2-d]oxepin-4,10(5H,6H)-dione,1,7,7a,11,11a,11b-hexahydro-1,6,11-trihydroxy-8,11a,14-trimethyl-,(1R,2S,5R,5aR,6R,7aS,11S,11aS,11bR,14S)- (9CI))

CAS号:
111567-19-2
中文名称:
2H-5a,2,5-(甲氧基亚甲基)萘[1,2-d]oxepin-4,10(5H,6H)-二酮,1,7,7a,11,11a,11b-六氢-1,6,11-三羟基-8,11a,14-三甲基-,(1R,2S,5R,5aR,6R,7aS,11S,11aS,11bR,14S)-(9CI)
英文名称:
2H-5a,2,5-(Methanoxymetheno)naphth[1,2-d]oxepin-4,10(5H,6H)-dione,1,7,7a,11,11a,11b-hexahydro-1,6,11-trihydroxy-8,11a,14-trimethyl-,(1R,2S,5R,5aR,6R,7aS,11S,11aS,11bR,14S)- (9CI)
分子式:
C19H24O7
分子量:
364.389666557312

2H-5a,2,5-(甲氧基亚甲基)萘[1,2-d]oxepin-4,10(5H,6H)-二酮,1,7,7a,11,11a,11b-六氢-1,6,11-三羟基-8,11a,14-三甲基-,(1R,2S,5R,5aR,6R,7aS,11S,11aS,11bR,14S)-(9CI)(111567-19-2)名称与标识符

名称

英文别名:
2H-5a,2,5-(Methanoxymetheno)naphth[1,2-d]oxepin-4,10(5H,6H)-dione,1,7,7a,11,11a,11b-hexahydro-1,6,11-trihydroxy-8,11a,14-trimethyl-,(1R,2S,5R,5aR,6R,7aS,11S,11aS,11bR,14S)- (9CI);2H-5a,2,5-(Methanoxymetheno)naphth[1,2-d]oxepin-4,10(5H,6H)-dione,1,7,7a,11,11a,11b-hexahydro-...;2H-5a,2,5-(Methanoxymetheno)naphth[1,2-d]oxepin-4,10(5H,6H)-dione,1,7,7a,11,11a,11b-hexahydro-1,6,11-trihydroxy-8,11a,14-trim;cedronin;Cedronine;(1R-(1alpha,2alpha,5alpha,5aalpha,6beta,7abeta,11alpha,11aalpha,11bbeta,14S*))-1,7,7a,11,11a,11b-Hexahydro-1,6,11-trihydroxy-8,11,14-trimethyl-2H-5a,2,5-(methanoxymethano)naphth(1,2-d)oxepin-4,10(5H,6H)-dione;1,6,11;2H-5a,2,5-(Methanoxymethano)naphth(1,2-d)oxepin-4,10(5H,6H)-dione, 1,7,7a,11,11a,11b-hexahydro-1,6,11-trihydroxy-8,11,14-trimethyl-, (1R-(1alpha,2alpha,5alpha,5aalpha,6beta,7abeta,11alpha,11aalpha,11bbeta,14S*))-;DTXSID30912223;NSC267707;NSC-267707;111614-53-0;1,6,11-Trihydroxy-8,11a,14-trimethyl-1,7,7a,11,11a,11b-hexahydro-2H-2,5,5a-(methanetriyloxymethano)naphtho[1,2-d]oxepine-4,10(5H,6H)-dione;7-epi-Cedronin;9,12,18-trihydroxy-4,11,15-trimethyl-3,7-dioxapentacyclo[8.8.0.01,5.04,8.011,16]octadec-14-ene-6,13-dione;111567-19-2;NSC283437;NSC-283437;CEDRONINE STEREOISOMER;(+)-Cedronin;

标识符

InChIKey:
FNBJCARFLWAAPK-UHFFFAOYSA-N
Inchi:
1S/C19H24O7/c1-7-4-9(20)14(23)17(2)8(7)5-10(21)19-6-25-18(3)13(19)16(24)26-15(18)11(22)12(17)19/h4,8,10-15,21-23H,5-6H2,1-3H3
SMILES:
O1CC23C(CC4C(C)=CC(C(C4(C)C2C(C2C1(C)C3C(=O)O2)O)O)=O)O

2H-5a,2,5-(甲氧基亚甲基)萘[1,2-d]oxepin-4,10(5H,6H)-二酮,1,7,7a,11,11a,11b-六氢-1,6,11-三羟基-8,11a,14-三甲基-,(1R,2S,5R,5aR,6R,7aS,11S,11aS,11bR,14S)-(9CI)(111567-19-2)物化性质

实验特性

  • PSA : 113.29
  • 折射率 : 1.637
  • 沸点 : 654.9°Cat760mmHg
  • 闪点 : 239.2°C
  • 密度 : 1.49

计算特性

  • 精确分子量 : 364.15222
  • 氢键供体数量 : 3
  • 氢键受体数量 : 7
  • 可旋转化学键数量 : 0
  • 同位素质量 : 364.152
  • 重原子数量 : 26
  • 复杂度 : 761
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 10
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -1
  • 拓扑分子极性表面积 : 113A^2